A Global Leader! Huawei Cloud Stack Ranks No. 1 in Strategy and Execution of CloudOps Worldwide

A Global Leader! Huawei Cloud Stack Ranks No. 1 in Strategy and Execution of CloudOps Worldwide

SHENZHEN, China, Feb. 14, 2025 /PRNewswire/ -- Omdia released the Omdia Universe: CloudOps, 2025 report recently. In the report, Huawei was ranked No. 1 globally in CloudOps in terms of strategy and execution, and No. 2 globally in terms of solution...

Appier provides strong FY25 guidance and a sustainable, profitable growth trajectory

Appier provides strong FY25 guidance and a sustainable, profitable growth trajectory

Agreement to acquire AdCreative.ai set to improve gross margins, enhance product synergies, and expand total addressable market Highlights and achievements for fiscal year 2024 Growth momentum persists in our key focus regions in FY24 led to an...

From O Levels to a Medicine, Dentistry or Law Degree in Just 9 Months

From O Levels to a Medicine, Dentistry or Law Degree in Just 9 Months

SINGAPORE, Feb. 11, 2025 /PRNewswire/ -- With the growing demand for doctors, Singapore has increased the number of recognised foreign medical schools and ambitious students aiming for careers in medicine, dentistry or even law now have an...

Turfan, Xinjiang: Deployment of a High-Throughput Satellite Station in the Power Grid

Turfan, Xinjiang: Deployment of a High-Throughput Satellite Station in the Power Grid

TURFAN, China, Feb. 8, 2025 /PRNewswire/ -- On February 8, State Grid Turfan Power Supply Company successfully commissioned a Ka-band high-throughput satellite portable station after multiple rounds of rigorous testing. Compared to traditional...

$50M historic gift fuels scholarships in coastal and marine sciences at William & Mary's Batten School & VIMS

$50M historic gift fuels scholarships in coastal and marine sciences at William & Mary's Batten School & VIMS

Alumnus provides largest scholarship gift in university's history; Investment in the next generation of scientists and leaders comes at a time of global crisis WILLIAMSBURG, Va., Feb. 6, 2025 /PRNewswire/ -- William & Mary's largest scholarship...

Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market

Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON, Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence and BioWorld...

The British Library Selects Clarivate to Provide Library Services and Discovery Platforms

The British Library Selects Clarivate to Provide Library Services and Discovery Platforms

Achieving more unified and secure workflows with cloud-based Alma, Primo and Rapido library software solutions from Clarivate LONDON, Jan. 28, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence,...

Ping An Bank Fuels Yulin Chemical's Green Transition With RMB2.3 Billion Loan

Ping An Bank Fuels Yulin Chemical's Green Transition With RMB2.3 Billion Loan

HONG KONG and SHANGHAI, Jan. 22, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", "the Company" or the "Group" HKEX: 2318 / 82318; SSE: 601318) announced that its subsidiary, Ping An Bank, has provided a...

Stena RoRo takes delivery of RoRo ship Giuseppe Lucchesi

Stena RoRo takes delivery of RoRo ship Giuseppe Lucchesi

GOTHENBURG, Sweden, Jan. 21, 2025 /PRNewswire/ -- Stena RoRo has expanded its fleet with the purchase of the RoRo ship Giuseppe Lucchesi . The ship will be renamed the Stena Shipper and fly the Danish flag. In connection with the transaction, Stena...

Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update

Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update

ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity, supporting once-daily or less frequent oral dosing. ASC30...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • menu
    menu